Clinical trial · Interventional
Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium
Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium: A Multicenter, Randomized, Double-Blind Clinical Trail
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Postoperative cognitive dysfunction (POCD) and postoperative delirium occurs mainly in aged patients. POCD and POD may increase the mortality and morbidity. However, the mechanism of POCD is not clear yet and no effective therapy method was proved. According to previous study, the neuroinflammation is the main reason both for POCD and POD. Minocycline is a tetracycline derivative. Due to it's lipophilic structure, it is easy to pass through blood brain barrier and attenuate neuroinflammation. It's neuroprotective effects has been proven in many experimental animal models such as Alzheimer's disease, Huntington's disease and Parkinson's syndrome. In present study, the investigators hypothesized that minocycline would attenuate the incidence of POCD and POD in the aged patients.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Carcinoma of the Rectum | Rectal Carcinoma | ALIAS | 0.90 |
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
| Renal Carcinoma | Kidney Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Minocycline | Drug | — | UNRESOLVED |
| Placebo | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- PLACEBO_COMPARATOR
- label
- Placebo
- description
- Placebo administered before surgery
- interventionNames
- Drug: Placebo
- type
- EXPERIMENTAL
- label
- Minocycline
- description
- Minocycline was administrated before surgery
- interventionNames
- Drug: Minocycline
- type
- NO_INTERVENTION
- label
- Volunteers
- description
- Health people for calculate the incidence of POCD
Primary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 65 Years
Show eligibility criteria text
For the placebo and minocycline group; Inclusion Criteria: 1. Elder than 65 years old 2. Speak Chinese Mandarin 3. Those who will undergo major general surgery like colorectal cancer excision, major urinary surgery like radical prostatectomy and radical nephrectomy 4. Signed the inform consent 5. American Society of Anesthesiologists classification I to III Exclusion Criteria: 1. Existing cerebral disease, or have a history of neurological and psychiatric diseases including Alzheimer Disease, stroke, epilepsy and psychosis; 2. Existing cognitive impairment as evidenced by Mini-Mental State Examination scores below 24; 3. Severe audition or vision disorder; 4. Unwillingness to comply with the protocol or procedures. 5. Cannot communicated with Chinese Mandarin 6. With severe skin disease 7. Serious heart or liver or renal insufficiency patients 8. Had surgery in the past 30 days 9. Allergy to tetracycline or minocycline For the health volunteers; Inclusion Criteria: 1. Elder than 65 years old 2. Speak Chinese Mandarin 3. Signed the inform consent 4. No major disease health people Exclusion Criteria: 1. Existing cerebral disease, or have a history of neurological and psychiatric diseases including Alzheimer Disease, stroke, epilepsy and psychosis; 2. Existing cognitive impairment as evidenced by Mini-Mental State Examination scores below 24; 3. Severe audition or vision disorder; 4. Unwillingness to comply with the protocol or procedures. 5. Cannot communicated with Chinese Mandarin 6. Drug abuse, alcoholism 7. Serious heart or liver or renal insufficiency patients 8. Had surgery in the past 30 days 9. Plan to undergo surgery in the following 3 months.
References
Publications (21)
- BACKGROUNDLarge MC, Reichard C, Williams JT, Chang C, Prasad S, Leung Y, DuBeau C, Bales GT, Steinberg GD. Incidence, risk factors, and complications of postoperative delirium in elderly patients undergoing radical cystectomy. Urology. 2013 Jan;81(1):123-8. doi: 10.1016/j.urology.2012.07.086. Epub 2012 Nov 13. PMID 23153950
- BACKGROUNDPol RA, van Leeuwen BL, Izaks GJ, Reijnen MM, Visser L, Tielliu IF, Zeebregts CJ. C-reactive protein predicts postoperative delirium following vascular surgery. Ann Vasc Surg. 2014 Nov;28(8):1923-30. doi: 10.1016/j.avsg.2014.07.004. Epub 2014 Jul 10. PMID 25017770
- BACKGROUNDNadelson MR, Sanders RD, Avidan MS. Perioperative cognitive trajectory in adults. Br J Anaesth. 2014 Mar;112(3):440-51. doi: 10.1093/bja/aet420. Epub 2014 Jan 2. PMID 24384981
- BACKGROUNDWesthoff D, Witlox J, Koenderman L, Kalisvaart KJ, de Jonghe JF, van Stijn MF, Houdijk AP, Hoogland IC, Maclullich AM, van Westerloo DJ, van de Beek D, Eikelenboom P, van Gool WA. Preoperative cerebrospinal fluid cytokine levels and the risk of postoperative delirium in elderly hip fracture patients. J Neuroinflammation. 2013 Oct 7;10:122. doi: 10.1186/1742-2094-10-122. PMID 24093540
- BACKGROUNDShim JJ, Leung JM. An update on delirium in the postoperative setting: prevention, diagnosis and management. Best Pract Res Clin Anaesthesiol. 2012 Sep;26(3):327-43. doi: 10.1016/j.bpa.2012.08.003. PMID 23040284
- BACKGROUNDvan Meenen LC, van Meenen DM, de Rooij SE, ter Riet G. Risk prediction models for postoperative delirium: a systematic review and meta-analysis. J Am Geriatr Soc. 2014 Dec;62(12):2383-90. doi: 10.1111/jgs.13138. PMID 25516034
- BACKGROUNDAmerican Geriatrics Society Expert Panel on Postoperative Delirium in Older Adults. Postoperative delirium in older adults: best practice statement from the American Geriatrics Society. J Am Coll Surg. 2015 Feb;220(2):136-48.e1. doi: 10.1016/j.jamcollsurg.2014.10.019. Epub 2014 Nov 14. No abstract available.